• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".

作者信息

Lyu Houchen, Zhao Sizheng S, Solomon Daniel H

机构信息

Division of Rheumatology, Brigham and Women's Hospital, Boston, Massachusetts, United States.

China National Clinical Research Center of Musculoskeletal Diseases, Beijing, China.

出版信息

J Clin Endocrinol Metab. 2020 May 1;105(5). doi: 10.1210/clinem/dgz123.

DOI:10.1210/clinem/dgz123
PMID:31650171
Abstract
摘要

相似文献

1
Reply to Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
J Clin Endocrinol Metab. 2020 May 1;105(5). doi: 10.1210/clinem/dgz123.
2
Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
J Clin Endocrinol Metab. 2019 Dec 1;104(12):5913-5914. doi: 10.1210/jc.2019-01650.
3
Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".
J Clin Endocrinol Metab. 2020 Mar 1;105(3). doi: 10.1210/clinem/dgz122.
4
Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use.比较特立帕肽和地舒单抗在长期使用双膦酸盐类药物的患者中的应用。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5611-5620. doi: 10.1210/jc.2019-00924.
5
Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis.生物制剂初治类风湿关节炎患者换用地舒单抗或每日特立帕肽对影像学关节破坏进展的影响。
Osteoporos Int. 2018 Jul;29(7):1627-1636. doi: 10.1007/s00198-018-4492-y. Epub 2018 Mar 24.
6
Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis.评估类风湿关节炎患者由口服双膦酸盐转换为地舒单抗或每日特立帕肽的效果。
J Bone Miner Metab. 2018 Jul;36(4):478-487. doi: 10.1007/s00774-017-0861-4. Epub 2017 Aug 1.
7
Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.与特立帕肽和地诺单抗序贯使用相关的双侧非典型股骨骨折复发：一例报告
Osteoporos Int. 2016 Feb;27(2):821-5. doi: 10.1007/s00198-015-3354-0. Epub 2015 Oct 12.
8
Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.低骨量绝经后女性循环中信号素-4D和丛状蛋白-B1水平：唑来膦酸、地诺单抗或特立帕肽治疗3个月的效果
Expert Opin Ther Targets. 2015 Mar;19(3):299-306. doi: 10.1517/14728222.2014.983078. Epub 2014 Nov 14.
9
Letter to the Editor: Combination Treatment With Teriparatide and Denosumab in Osteoporosis.致编辑的信：特立帕肽与地诺单抗联合治疗骨质疏松症
J Clin Endocrinol Metab. 2016 Aug;101(8):L80-1. doi: 10.1210/jc.2016-2343.
10
Using Osteoporosis Therapies in Combination.联合使用骨质疏松症疗法。
Curr Osteoporos Rep. 2017 Aug;15(4):343-352. doi: 10.1007/s11914-017-0376-x.